Why the study?
Does tailored antiplatelet therapy based on platelet function testing improve clinical outcomes in patients undergoing PCI compared to standard therapy?
Does tailored antiplatelet therapy based on platelet function testing improve clinical outcomes in patients undergoing PCI compared to standard therapy?
This review explores the clinical implications of variability in response to dual antiplatelet therapy in patients undergoing PCI and the potential for personalized therapy.
No takes yet. Share an insight, caveat, or question.
May support personalized DAPT strategies post-PCI; leaves open whether platelet function testing improves outcomes over standard therapy.
Curzen et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: